The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo

Abstract Background Pancreatic cancer is one of the leading causes of cancer death in Western societies. Its late diagnosis and resistance to chemotherapies result in a high mortality rate; thus, the development of more effective therapies for the treatment of pancreatic cancer is strongly warranted...

Full description

Bibliographic Details
Main Authors: Mariola Gimła, Agnieszka Pyrczak-Felczykowska, Marcelina Malinowska, Aleksandra Hać, Magdalena Narajczyk, Irena Bylińska, Tristan A. Reekie, Anna Herman-Antosiewicz
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-023-03054-x
_version_ 1797556317853843456
author Mariola Gimła
Agnieszka Pyrczak-Felczykowska
Marcelina Malinowska
Aleksandra Hać
Magdalena Narajczyk
Irena Bylińska
Tristan A. Reekie
Anna Herman-Antosiewicz
author_facet Mariola Gimła
Agnieszka Pyrczak-Felczykowska
Marcelina Malinowska
Aleksandra Hać
Magdalena Narajczyk
Irena Bylińska
Tristan A. Reekie
Anna Herman-Antosiewicz
author_sort Mariola Gimła
collection DOAJ
description Abstract Background Pancreatic cancer is one of the leading causes of cancer death in Western societies. Its late diagnosis and resistance to chemotherapies result in a high mortality rate; thus, the development of more effective therapies for the treatment of pancreatic cancer is strongly warranted. Usnic acid (UA) is a secondary metabolite of lichens that shows modest antiproliferative activity toward cancer cells. Recently, we reported the synthesis of a UA pyrazole derivative, named 5, which was more active than the parent compound toward cervical cancer cells. Here, its anticancer potential has been evaluated in detail in other cancer cells, particularly pancreatic cancer cells. Methods The impact of UA and derivative 5 on cell viability, morphology, cell cycle, and death was assessed using the MTT test, electron microscopy, flow cytometry, and immunoblotting, respectively. The calcium ions level was detected fluorometrically. In vivo, the anticancer activity of 5 was evaluated in a murine xenograft model. Results Derivative 5 inhibited the viability of different cancer cells. Noncancerous cells were less sensitive. It induced the release of calcium ions from the endoplasmic reticulum (ER) and ER stress, which was manifested by cell vacuolization. It was accompanied by G0/G1 cell cycle arrest and cell death of pancreatic cancer cells. When applied to nude mice with xenografted pancreatic cancer cells, 5 inhibited tumor growth, with no signs of kidney or liver toxicity. Conclusions UA derivative 5 is superior to UA inhibiting the growth and proliferation of pancreatic cancer cells. ER stress exaggeration is a mechanism underlying the activity of derivative 5.
first_indexed 2024-03-10T17:01:08Z
format Article
id doaj.art-a79a4e7d4fe2412fbfbf03f33d37247b
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-03-10T17:01:08Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-a79a4e7d4fe2412fbfbf03f33d37247b2023-11-20T10:59:13ZengBMCCancer Cell International1475-28672023-09-0123111310.1186/s12935-023-03054-xThe pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivoMariola Gimła0Agnieszka Pyrczak-Felczykowska1Marcelina Malinowska2Aleksandra Hać3Magdalena Narajczyk4Irena Bylińska5Tristan A. Reekie6Anna Herman-Antosiewicz7Department of Medical Biology and Genetics, Faculty of Biology, University of GdańskDepartment of Physiology, Medical University of GdańskDepartment of Medical Biology and Genetics, Faculty of Biology, University of GdańskDepartment of Medical Biology and Genetics, Faculty of Biology, University of GdańskElectron Microscopy Section, Faculty of Biology, University of GdańskDepartment of Biomedical Chemistry, Faculty of Chemistry, University of GdańskSchool of Science, University of New South Wales Canberra, Australian Capital TerritoryDepartment of Medical Biology and Genetics, Faculty of Biology, University of GdańskAbstract Background Pancreatic cancer is one of the leading causes of cancer death in Western societies. Its late diagnosis and resistance to chemotherapies result in a high mortality rate; thus, the development of more effective therapies for the treatment of pancreatic cancer is strongly warranted. Usnic acid (UA) is a secondary metabolite of lichens that shows modest antiproliferative activity toward cancer cells. Recently, we reported the synthesis of a UA pyrazole derivative, named 5, which was more active than the parent compound toward cervical cancer cells. Here, its anticancer potential has been evaluated in detail in other cancer cells, particularly pancreatic cancer cells. Methods The impact of UA and derivative 5 on cell viability, morphology, cell cycle, and death was assessed using the MTT test, electron microscopy, flow cytometry, and immunoblotting, respectively. The calcium ions level was detected fluorometrically. In vivo, the anticancer activity of 5 was evaluated in a murine xenograft model. Results Derivative 5 inhibited the viability of different cancer cells. Noncancerous cells were less sensitive. It induced the release of calcium ions from the endoplasmic reticulum (ER) and ER stress, which was manifested by cell vacuolization. It was accompanied by G0/G1 cell cycle arrest and cell death of pancreatic cancer cells. When applied to nude mice with xenografted pancreatic cancer cells, 5 inhibited tumor growth, with no signs of kidney or liver toxicity. Conclusions UA derivative 5 is superior to UA inhibiting the growth and proliferation of pancreatic cancer cells. ER stress exaggeration is a mechanism underlying the activity of derivative 5.https://doi.org/10.1186/s12935-023-03054-xCancerUsnic acidEndoplasmic reticulum stressCell deathLichensVacuolization
spellingShingle Mariola Gimła
Agnieszka Pyrczak-Felczykowska
Marcelina Malinowska
Aleksandra Hać
Magdalena Narajczyk
Irena Bylińska
Tristan A. Reekie
Anna Herman-Antosiewicz
The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
Cancer Cell International
Cancer
Usnic acid
Endoplasmic reticulum stress
Cell death
Lichens
Vacuolization
title The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
title_full The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
title_fullStr The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
title_full_unstemmed The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
title_short The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
title_sort pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
topic Cancer
Usnic acid
Endoplasmic reticulum stress
Cell death
Lichens
Vacuolization
url https://doi.org/10.1186/s12935-023-03054-x
work_keys_str_mv AT mariolagimła thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT agnieszkapyrczakfelczykowska thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT marcelinamalinowska thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT aleksandrahac thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT magdalenanarajczyk thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT irenabylinska thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT tristanareekie thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT annahermanantosiewicz thepyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT mariolagimła pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT agnieszkapyrczakfelczykowska pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT marcelinamalinowska pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT aleksandrahac pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT magdalenanarajczyk pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT irenabylinska pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT tristanareekie pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo
AT annahermanantosiewicz pyrazolederivativeofusnicacidinhibitstheproliferationofpancreaticcancercellsinvitroandinvivo